Acthera Therapeutics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Out of Business

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Liquidation

Acthera Therapeutics General Information

Description

Developer of hard-shelled liposomes designed to optimize the therapeutic effect while minimizing the side effects. The company's proprietary liposomes (hard-shelled liposomes, HSL) allow for the highly targeted release of therapeutic molecules at the exact site of the pathological process of the disease, enabling clinicians to increase the efficacy and decrease the side effects, as a way to widen the therapeutic window of drugs.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Grosspeteranlage 29
  • 4052 Basel
  • Switzerland
+41 077
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Biotechnology
Corporate Office
  • Grosspeteranlage 29
  • 4052 Basel
  • Switzerland
+41 077

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Acthera Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Bankruptcy: Liquidation Completed Pre-Clinical Trials
8. Seed Round 01-Jun-2022 Completed Pre-Clinical Trials
7. Early Stage VC Cancelled Pre-Clinical Trials
6. Early Stage VC Cancelled Pre-Clinical Trials
5. Seed Round 02-Sep-2021 Completed Pre-Clinical Trials
4. Seed Round 13-Jan-2021 Completed Startup
3. Seed Round 05-Jul-2020 Completed Startup
2. Angel (individual) 01-Nov-2019 $856K $856K Completed Startup
1. University Spin-Out 01-Jan-2019 Completed Startup
To view Acthera Therapeutics’s complete valuation and funding history, request access »

Acthera Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary 508,824 $0.102081 $2.14 $2.14 1x $2.14 12.09%
Ordinary 500,000 $0.102081 $1.74 $1.74 1x $1.74 11.89%
To view Acthera Therapeutics’s complete cap table history, request access »

Acthera Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of hard-shelled liposomes designed to optimize the therapeutic effect while minimizing the side effects. The c
Drug Delivery
Basel, Switzerland
3 As of 2024

Utrecht, Netherlands
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Acthera Therapeutics Competitors (1)

One of Acthera Therapeutics’s competitors is TargED Biopharmaceuticals, a Venture Capital-Backed company based in Utrecht, Netherlands.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
TargED Biopharmaceuticals Venture Capital-Backed Utrecht, Netherlands
You’re viewing 1 of 1 competitors. Get the full list »

Acthera Therapeutics Patents

Acthera Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2019253085-A1 Noble metal-coated mechanoresponsive vesicles Inactive 13-Apr-2018
CA-3096676-A1 Noble metal-coated mechanoresponsive vesicles Pending 13-Apr-2018
EP-3774822-A1 Noble metal-coated mechanoresponsive vesicles Inactive 13-Apr-2018
EP-3774822-A4 Noble metal-coated mechanoresponsive vesicles Inactive 13-Apr-2018
US-20210170054-A1 Noble metal-coated mechanoresponsive vesicles Inactive 13-Apr-2018 A61K9/0002
To view Acthera Therapeutics’s complete patent history, request access »

Acthera Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Acthera Therapeutics FAQs

  • When was Acthera Therapeutics founded?

    Acthera Therapeutics was founded in 2019.

  • Where is Acthera Therapeutics headquartered?

    Acthera Therapeutics is headquartered in Basel, Switzerland.

  • What is the size of Acthera Therapeutics?

    Acthera Therapeutics has 3 total employees.

  • What industry is Acthera Therapeutics in?

    Acthera Therapeutics’s primary industry is Drug Delivery.

  • Is Acthera Therapeutics a private or public company?

    Acthera Therapeutics is a Private company.

  • What is Acthera Therapeutics’s current revenue?

    The current revenue for Acthera Therapeutics is .

  • How much funding has Acthera Therapeutics raised over time?

    Acthera Therapeutics has raised $9.3M.

  • Who are Acthera Therapeutics’s competitors?

    TargED Biopharmaceuticals is a competitor of Acthera Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process